Jennifer R. Brown, MD, PhD | Authors


Unmet Needs in Frontline Treatment of CLL

March 29, 2021

The shortcomings physicians face in combatting CLL (chronic lymphocytic leukemia) are discussed, in addition to what the high-level updates from the ELEVATE-RR press release may reveal regarding future treatments for CLL.

Pooled Analysis Supports Use of Acalabrutinib in Patients With Chronic Lymphocytic Leukemia

December 07, 2020

Jennifer R. Brown, MD, PhD, discusses the implications of the findings from a pooled analysis of cardiovascular events from studies of the next-generation BTK inhibitor acalabrutinib monotherapy as treatment of patients with chronic lymphocytic leukemia.